BSX241129C97000
- 0.00
- 0.000.00%
Boston Scientific Newsroom
$100 Invested In Boston Scientific 10 Years Ago Would Be Worth This Much Today
JPMorgan Updates Its U.S. Analyst Focus List – Adds TPR, ALRM, REG
Boston Scientific Shares Positive Acurate Prime XL TAVR Data
Express News | Boston Scientific Corp: Specific Terms of Transaction Have Not Been Disclosed
Express News | Boston Scientific Corp - Transaction Expected to Be Dilutive on Gaap Basis in 2025
Express News | Boston Scientific Announces Agreement to Acquire Intera Oncology® Inc.
Press Release: Boston Scientific Announces Agreement to Acquire Intera Oncology(R) Inc.
Boston Scientific Announces Agreement to Acquire Intera Oncology Inc.
Boston Scientific Insider Sold Shares Worth $446,902, According to a Recent SEC Filing
Boston Scientific Launches 2025 Incentive Programs
Why Is Boston Scientific (BSX) Up 7.5% Since Last Earnings Report?
Boston Scientific (NYSE:BSX) Jumps 4.5% This Week, Though Earnings Growth Is Still Tracking Behind Three-year Shareholder Returns
Boston Scientific Corporation (BSX)'s Breakthroughs: A Hidden Gem in Billionaire Ken Griffin's Portfolio
Piper Sandler Maintains Boston Scientific(BSX.US) With Buy Rating, Raises Target Price to $95
Piper Sandler Releases a Buy Rating on Boston Scientific (BSX)
Boston Scientific's Growth Potential Boosted by Positive OPTION Trial Results and Regulatory Developments
JPMorgan's 'Analyst Focus List' – Growth, Income, Value, Short Ideas
Abbott Reports Positive Amplatzer Amulet Data in Head-to-head Trial With Boston Scientific's Watchman
A Quick Look at Today's Ratings for Boston Scientific(BSX.US), With a Forecast Between $98 to $100
BSX Stock Gains From Positive OPTION Trial Data for WATCHMAN FLX